Kendle has opened a new office in Ann Arbor, MI, expanding its Phase II-IV clinical development services for its biopharmaceutical customers. The new office also creates opportunities for the region. “With the University of Michigan nearby, Ann Arbor as a region is increasing its commitment to become a hub of biotech activity,” said Kendle’s senior vice president, global clinical development, North America, Martha Feller, Ph.D. “Building on a year in which we experienced significant growth...